Development of vaccines for combating viruses such as Corona19. Proposal of filter concept applying advanced convergence technology and process concept for minimizing impurities in the process of acquiring base materials.

摘要

The conventional method of obtaining the base material for vaccine development was the concept of collecting the blood of a person who had already been infected with a virus and then separating the plasma from it, and developing a therapeutic material using this as the base material for vaccine development. In this case, unexpected impurities are contained in the separated plasma. As a result, there is a risk that various side effects may occur. As a concept of minimizing or zeroing impurities in plasma, which is a problem to be solved in the present invention, it is necessary to apply the same concept as the attached process. In addition, as an advanced technology for the method of minimizing or zeroing impurities in plasma, which is a problem to be solved in the present invention, basalt (Jeju basalt is effective) and nano-filter (carbon compound containing germanium is effective) is physically fused. Incorporating a new filter that has been In the present invention, it is intended to present the following process as specific content for carrying out the invention. 1. After being infected with a virus such as COVID-19, blood is collected from a person who has been cured and cured. 2. Plasma is separated from the collected blood, and types A (AA, AO division), B type (BB, BO division), AB type, O type, each type and especially RH+ and RH- must be divided. 3. Pass the filter (basalt, nano germanium) developed by convergence by advanced technology under the condition of maintaining the temperature of 36.5 degrees. 4. The basic material of the ''vaccine development base material'' that has passed through the filter is maintained and stored under the condition that the temperature is maintained at -20 degrees.